Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Inspiris Resilia valve in pulmonary position- single center experience and literature review
Session:
Prémio Manuel Machado Macedo
Speaker:
Francisca Castro
Congress:
CPC 2026
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Sessão de Prémios
FP Number:
---
Authors:
Maria Francisca Castro; Pedro Lamares Magro; Marta Pereira Marques; João Aquino; Inês Alves; Maria Resende
Abstract
<p style="text-align:justify"><span style="font-size:12px"><strong>Abstract</strong></span></p> <p style="text-align:justify"><span style="font-size:12px"><strong>Introduction</strong>: Pulmonary valve (PV) disease is frequently encountered in congenital heart disease, yet evidence guiding the optimal valve substitute remains limited. The Inspiris Resilia (IR) bioprosthesis, designed to improve durability through novel pericardial tissue technology, has shown promising performance in the aortic position. However, data on its use in the pulmonary position are scarce and conflicting.</span></p> <p style="text-align:justify"><span style="font-size:12px"><strong>Purpose</strong>: This study evaluates a single-center experience with IR valves implanted in the PV position and reviews current literature.</span></p> <p style="text-align:justify"><span style="font-size:12px"><strong>Methods</strong>: A retrospective observational study was conducted including all patients who underwent pulmonary valve replacement with an IR prosthesis from 2011 to 2025. Demographic, surgical, and early postoperative data were collected. Long-term follow-up assessed echocardiographic performance, reintervention, and mortality. Descriptive statistics were used, and freedom from reintervention or significant pulmonary regurgitation was analyzed usingh the Kaplan–Meier method.</span></p> <p style="text-align:justify"><span style="font-size:12px"><strong>Results</strong>: Nineteen patients received an IR pulmonary valve (mean age 28.9 ± 18.7 years; 42% ≤18 years). Most had repaired Tetralogy of Fallot as the main diagnosis (79%). Mean prosthesis size was 25.7 ± 3.1 mm. In-hospital mortality was 10.5%. Among the 17 patients discharged alive, no reinterventions occurred during follow-up. Mid-to-long-term echocardiography demonstrated stable gradients (mean 17.8 mmHg), with 5 mild, 2 moderate, and 1 severe pulmonary regurgitation. No late mortality was observed.</span></p> <p style="text-align:justify"><span style="font-size:12px"><strong>Conclusion</strong>: In this single-center cohort, IR valves in the pulmonary position demonstrated good mid-term outcomes without any observed reinterventions.</span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site